A study led by Dr. Faiyaz Notta @pmcancercentre@UHN provides a molecular classification scheme for BCR-ABL1 lymphoblastic #leukemia, offering insights into therapy resistance and potential treatment strategies.
Read in Nature Genetics @NatureGenet: https://t.co/WEiafHosqY
https://t.co/hE8wV3oYrI
@LabNotta@UHN@OICR_news Our paper on “Transcriptomic classes of BCR-ABL1 lymphoblastic leukemia” is finally published! Congrats to the Notta lab and everyone involved. To highlight some of the main findings..
The @LabNotta is honoured to be one of the awardees. With the support of @ONgov we will use three dimensional culture systems to elucidate the cellular and molecular mechanisms that regulate the development of pancreatic cancer. @UHN_Research
Researchers from SickKids & @NUFeinbergMed created a novel protein therapeutic that slows tumour growth in the lab by targeting RAS proteins seen in nearly a third of all human cancers, opening the door to future therapies.
Read more: https://t.co/N5a8lmfsJi #SKResearch
New results indicate that surgical face masks could prevent transmission of human #coronavirus (and #flu) from symptomatic individuals - Read now: https://t.co/SmYMaHY8BC @bencowling88@HKUniversity#COVID19
Our lab’s first paper - Novel molecular subtypes of pancreatic cancer through transcriptomics and genomics analysis. Basal and classical signatures co-exist in PDAC tumors and tracked using #10xgenomics#SingleCell RNA-seq.